Dr. Cannon’s research is focused on viruses, stem cells and gene therapy. The viruses that her laboratory studies are HIV-1 and several biodefense related viruses, such as Ebola and Junin, that cause severe viral hemorrhagic fevers.
Stories
Three USC researchers win $4.3 million in awards from California’s stem cell agency
Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding …
USC Stem Cell Symposium creates scientific synergy
Provost Michael Quick convened the inaugural USC Stem Cell Symposium with a straightforward truth about the future of regenerative medicine: “it will take a dedicated community of scholars across the disciplines to …
USC hosts California stem cell agency’s tenth birthday bash
Few 10 year olds have brought 10 potential medical treatments into clinical trials. The California Institute for Regenerative Medicine (CIRM), however, is a truly exceptional 10 year old. In 2004, the people …
USC Stem Cell researchers share a vision of the future at the Milken Institute Global Conference
What do former British Prime Minister Tony Blair and singer Will.i.am have in common? They both attended this year’s Milken Institute Global Conference, where USC Stem Cell researchers offered an exciting glimpse …
Stem cells prove their potency at CHLA annual symposium
The Saban Research Institute of Children’s Hospital Los Angeles Annual Symposium, held on Feb. 21, focused on the promise of regenerative medicine and cellular therapies — from curing HIV to building organs …
Keck School researchers to speak at World Stem Cell Summit
Faculty researchers and clinicians from the Keck School of Medicine of USC are among more than 170 speakers who will discuss their efforts to zero in on disease cures at an international …
USC researchers create HIV-resistant cells
Researchers at the Keck School of Medicine of the University of Southern California (USC) have successfully transplanted blood stem cells modified to be resistant to HIV into mice, allowing the animals to …